Journal of Lymphoedema: A New Treatment for Soft-Tissue Fibrosis in the Breast

Abstract Background:

Soft tissue fibrosis is a common consequence of breast cancer treatment and chronic lymphoedema. It can compromise function and quality of life, but research regarding interventions is limited. Aims: To assess the efficacy of using JoViPitPak® (JoviPak Corporation) to influence soft tissue fibrosis change by looking at tissue density, perceived cosmesis and perceived breast pain. Methods: This case series examined four breast cancer patients with stage 2 lymphoedema, post lumpectomy surgery and radiation therapy. All patients were instructed in manual lymphatic drainage (MLD) and utilised elastic compression for breast oedema before receiving treatment for soft tissue fibrosis. Treatment consisted of using JoViPitPak®, a compression garment developed specifically for treatment of soft tissue fibrosis, which was worn upon the breast under elastic compression for two hours each day for three weeks. Pre- and post-treatment fibrosis was assessed with tissue tonometry, perception of cosmesis was assessed with a questionnaire, and breast pain was measured using an analogue pain scale. Results: Patients demonstrated decreased tissue density, increased perceived cosmesis and a decrease in perceived breast pain. Conclusion: The JoViPitPak® was efficacious in reducing the effects of soft tissue fibrosis. Additional randomised studies are warranted to further assess the efficacy of this treatment approach. Declaration of interest: None.